Appendix IV Research Work Group Report

Prepared by the Research Work Group of the
Subcommittee on Risk Management Committee
Coordinate Environmental Health and Related Programs

April 3, 1992

Research Work Group Leader:
Stanford Hamburger, D.D.S., M.P.H. Food and Drug Administration

Research Work Group Members:
Thomas Callahan, Ph.D. - Food and Drug Administration
Stephen Corbin, D.D.S., M.P.H. Centers for Disease Control and Prevention
Jeffery Gift, Ph.D. - Environmental Protection Agency
Peggy Hamilton - Food and Drug Administration
Annie Jarabek - Environmental Protection Agency
Mark McClanahan, Ph.D. - Centers for Disease Control and Prevention
Kevin Tonat, M.P.H. - National Institutes of Health

INTRODUCTION

A major concern facing the public health and professional communities, as well as the public, is the potential for adverse health effects associated with the use of dental amalgam/mercury restorative materials. This concern has led the Public Health Service (PHS) to develop comprehensive scientific reviews of the risks and benefits of dental amalgam use. Pursuant to these reviews, the Committee to Coordinate Environmental and Health Related Programs (CCEHRP), through its Risk Management Subcommittee (RMS), formed three work groups to develop reports addressing professional and public education, regulation, and research recommendations related to the use of dental amalgam and human health. This report by the Research Work Group (RWG) is in response to five charges that were provided by the RMS as follows:

  1. Evaluate the research recommendations presented in the risks and benefits report.
  2. Develop rating criteria for identifying and prioritizing research initiatives.
  3. Address the viability of developing an intramural tracking mechanism to ensure that meritorious research projects are properly considered and funded within the PHS.
  4. Advise whether the use of dental sealants and other preventive restorations can further reduce the incidence of caries and, thus, the need for amalgam restorations.
  5. In consultation with the Regulation Work Group, examine the relevance and utility of adverse effects information collected from FDA's Medical Device Reporting System and Problem Reporting Programs (MDRs and PRP, respectively) for ongoing and future research initiatives, and explore means for exporting such data to government and private researchers.

The RWG conducted extensive discussions of the charges which resulted in general agreement that the philosophical approach would be based on the public health aspect(s) of scientific research with an emphasis on what research would best address two important public health policy questions:

"Should dental amalgam continue to be recommended for use?" and, if not,

"Should existing dental amalgam restorations be removed and replaced with another material?"

These policy questions cannot be addressed with confidence until we obtain answers to several fundamental questions relative to potential adverse effects of mercury on human health that include:

Similar to the issues of lead neurotoxicity, mechanistic research on mercury toxicity and the dynamics of its release from dental amalgams is crucial given the limitations of epidemiologic evidence. Issues such as measuring doseresponse at very low levels, bioavailability, relative persistence of the effects of early exposures, and the identification of critical periods of sensitivity will not be identified by epidemiologic studies alone. Such studies are generally imprecise in terms of dose and they are frequently confounded by the multitude of variables present in human populations.

It is important to recognize that the changing manner of dental practice has a continuing impact on how dental amalgam is used and how its "risks" and "benefits" are assessed. Average caries scores, especially for children and adolescents, continue to diminish. This reduction is largely attributable to the widespread use of fluorides, especially community water fluoridation. Dental amalgam remains the most commonly used dental restorative material, with nearly 50 percent of dental restorative procedures still involving the use of dental amalgams. However, its use is declining as caries scores decline and alternative materials are substituted. Effective preventive methods (e.g. sealants) and the utilization of new and improved materials and techniques now permit a wider spectrum of clinical choices.

Charge 1: To evaluate research recommendations presented
in the risks and benefits reports.

Background

The members of the RWG reviewed and accepted the amalgam benefits and risks reports as expert reviews and used them as a starting point for identifying and characterizing research needs. Numerous research recommendations were included in the reports, some general and some specific.

Each RWG member was asked initially to review and evaluate these recommendations. Additionally, RWG members were asked to identify questions or items suggested in the text of those reports that were not specifically addressed in the recommendations sections. These, in addition to the NIH Technology Assessment Conference document entitled Dental Restorative Materials and the recent FDA Dental Panel Report, comprise a rather complete inventory on amalgam safety and benefit issues. Additionally, research recommendations from the WHO International Programme on Chemical Safety (IPSC) Environmental Health Criteria 118 Inorganic Mercury were also considered.

Findings

Based on recent literature reviews, we conclude that several critical parameters relating to mercury toxicity and human health are unresolved: the specific health effects of low level mercury exposure, if any; the relevant absorption, distribution, metabolism, and elimination; putative biological markers of exposure and effect; the medical consequences; and, the significance of blood, urine, or tissue levels of mercury. Observations from the source reports cited that support this conclusion include the following:

  1. The putative human health effects of mercury are not well established or pathognomonic at low levels of exposure.
  2. Reported exposure levels are not consistent and are widely divergent. There is probably no zero-level of human exposure to mercury.
  3. Direct human data are inadequate and subject to confounding. Although, adverse human health effects from high mercury levels are documented from occupational exposure, these studies are not adequate for making decisions about risks from low-level exposure.
  4. Experimental animal data are inadequate and/or not helpful (e.g., sheep and rodent data may not be relevant to humans) because principal exposure may not be due to the vapor components.
  5. There are no consistently accepted criteria from which to assess the failure of a restoration.
  6. The exact mechanism of action of neurotoxicity from mercury is not established.
  7. No complete quantitative risk assessment, including risk chain has been presented.
  8. The mercury exposure and related health effects that may accompany removal of dental amalgam restorations as compared to not removing existing amalgam restorations have not been clearly established.
  9. Information supporting the safety of alternative materials may be no more sufficient than the information available on risks or benefits of exposure to dental amalgams.

Charge 2: To develop rating criteria for identifying
and prioritizing research initiatives.

Background

The RWG discussed extensively the merits of developing a numerically based ranking system for purposes of establishing research priorities relative to dental amalgam. It was recognized that even if such a system were to be developed, its validity, objectivity, and usefulness would remain to be determined. Similar issue-specific systems or a generic system have not yet been developed for ranking research needs and opportunities in other CCEHRP areas of concern to the Work Group's knowledge. Additionally, it was apparent, after review of the risks and benefits reports, that there are so many areas meriting additional scientific research, developing a special ranking instrument at this time may be superfluous.

As an alternative approach, members of the RWG independently reviewed the risks and benefits reports, along with the abstracts from the NIH Technology Assessment Conference, and the WHO IPSC report and developed lists of research questions and needs. The RWG then employed an iterative delphi type process to develop a list of the most fundamental and important areas for research that could practically be pursued in the immediate future. These are areas felt to be most critical to sound public health decision-making. Notwithstanding this approach, a more extensive list of issues meriting additional research attention, reflecting an integration of individual RWG member efforts, are identified in Attachment 1 of this report.

Findings

Two major areas of research questions were identified—questions that were principally methodological or those that were substantive relative to the effects and mechanisms of mercury actions on human health, whether from dental amalgam or other sources.

Priority Areas For Research

Additional methodological concerns include:

Recommendations

Very specific research questions/ studies/designs should be reviewed by experts in the topical subject areas. An extensive list of currently funded research projects is appended (Attachment 2) that reflects RWG consensus as bearing on many of the scientific questions at issue.

Charge 3: To address the viability of developing an intramural
tracking mechanism to insure that meritorious research projects
are properly considered and funded within the Public Health Service.

Background

The RWG adopted the position that existing intramural research projects, whether conducted by PHS researchers or through extramural grants, are meritorious by virtue of the review processes they must undergo before approval or award.

A first approximation of research projects relevant to dental toxicity, mercury amalgam, and alternative dental restorative materials conducted throughout the PHS was obtained by conducting several searches of the PHS CRISP database (Attachment 2).

In order to ensure that duplicative efforts would be minimized, the RWG consulted with the CCEHRP Subcommittee on Research Needs on its concurrent efforts to develop a research tracking system for specific areas of interest to CCEHRP.

Findings

An Intramural tracking mechanism to identify and monitor research projects funded within the PHS is a viable undertaking. Alternative mechanisms of obtaining relevant information, such as CRISP (Attachment 3), are available but do not currently address the full requirement of this charge.

Recommendations

The system should be clearly distinguished from a system to track recipients of dental amalgam or a postmarket surveillance system. This system would essentially be a registry of research projects supported and/or sponsored by PHS agencies. The administration of a system is of prime importance. Since it is to encompass all of the PHS and is to be a tool for the Assistant Secretary for Health (ASH), it should be administered by that office and could be delegated by the ASH to a lead agency or committee. In order to be comprehensive, the system should include information from sister agencies (i.e., EPA, DOD) and the private sector.

A proposed intramural tracking system should incorporate, at a minimum the following information for each project:

  1. Funding agency
  2. Program title
  3. Description of project
  4. Purpose of this project
  5. When results are expected
  6. Linkages between anticipated outcome measures and actual findings
  7. Milestones
  8. Anticipated accomplishments
  9. Categories: Basic sciences; Toxicology; Epidemiology; Clinical practice; Public health risk management (science. clinical)

All agencies would need access to the system in order to be able to identify areas of current and needed research and to decide how they would like to prioritize or solicit grant applications or project requests. Cooperation from participating agencies will be vital in order to establish a system that will be a viable tool for agency manages.

Charge 4: To advise whether the use of dental sealants  and other preventive restoration can further reduce the incidence of caries and thus, the need for amalgam restorations.

Background

Dental amalgam restorations have long been the mainstay of dental restorative practice. In fact, in previous decades when dental caries scores were much higher than today, it was not uncommon for many individuals to have dental amalgam restorations in virtually all their posterior teeth. Declining caries scores are a result of widespread preventive efforts, largely fluorides in drinking water and dental products. Dental sealants, which have been available for two decades, have only recently come into increasing prominence. In 1989, approximately 13% of 8-year-olds and 17 percent of 14-year-olds had received dental sealants. The PHS, through the Healthy People 2000 initiative, has established the goal that by the Year 2000, 50 percent of children will have received dental sealants.

Sealants prevent caries by acting as barriers. Sealants fill surface pits and fissures that are prone to the development of caries. Caries protection may be determined by the sealants' ability to remain adhered to the tooth. As long as the sealant remains intact, caries will not develop beneath it. However, even where sealants have been partially lost, some protection may be gained from residual sealant occluding the depth of the pit or fissure. Still, the longevity of a sealant on a tooth is a prime determinant of success. Sealants are underused in both private and public health care delivery systems. Expanding the use of sealants would reduce the occurrence of dental caries in the population, and particularly among children.

Findings

The report on the benefits of dental amalgam has concluded, based on extensive scientific evidence, that dental sealants are extremely effective in preventing decay in the pits and fissures that are common to the chewing surfaces of the posterior teeth This is important since fluoride is only partially effective in preventing caries on these surfaces.

Historically, the near universal choice for dental restorative material in the majority of restoration situations for posterior teeth has been amalgam. However, newer materials and techniques, most notably the preventive resin restoration, and improved composite materials are modifying the "standard" choice in defined situations. With an ever strengthening commitment to preserving as much sound tooth structure as possible, dentists are increasingly relying on non-amalgam restorative materials where the physical stress requirements of a particular restorative situation permit. Plastic filling materials can be used by themselves or in combination with sealants where the extent of caries is conservative. Acid etching techniques that enhance retention of the restorations are substituted for the creation of undercut areas in the tooth preparation to prevent dislodgement. This results in the removal of less sound tooth structure.

Another alternative to dental amalgam in defined restorative situations are the glass ionomers. Since these materials do not resist stress well, they cannot be used in areas of heavy occlusal contact. They offer an added advantage of containing fluoride that can leach out and provide a supplemental caries preventive effect. Glass ionomers, like resins, are tooth colored and thus superior to dental amalgam from an esthetics standpoint.

Still, it must be remembered that the majority of posterior restorative situations do not permit the use of plastic fillings or glass ionomers. This is particularly true of replacement restorations that may need to be large or that restore areas of heavy occlusal contact. With caries scores declining in children and with individual carious lesions being generally less extensive than in the past, there is likely to be increasing substitution of these alternative materials for dental amalgam in the future.

Recommendations

Expanding the use of dental sealants and alternative materials to dental amalgam, where appropriate, should be promoted to the public and the dental profession.

Charge 5: In consultation with the Regulation Work Group, examine the relevance and utility of adverse effects information—collected from FDA's Medical Device Reporting and Problem Reporting Programs—for ongoing and future research initiatives, and explore means for exporting such data to government and private researchers .

Background

Historically, little use has been made of the reporting system for dentally-related concerns. Thus, it has been of little utility for research purposes.

Findings

The relevance and utility of adverse effects information collected from the Food and Drug Administrations's MDRs and PRP for ongoing and future research is limited. A plethora of reports have been filed with chief complaints that were claimed to be resolved with the removal of amalgam/mercury restorations.

These reports, on relatively few subjects, may reflect a "selection bias." Approximately 550 reports have been entered into the system. The patients were self-selected and not representative of the general population. Representativeness is a basic requirement underlying statistical analysis. Preliminary frequencies relative to age, geographical distribution, and symptoms can only be considered as counts. The lack of population based data for comparisons severely limits any useful determinations. Reporting on these systems is not intended to provide precise quantifications of actual population-based risks. The MDRs and PRP are most useful for preliminary assessments of whether more formal surveillance or specialized studies are merited.

Recommendations

Only aggregate data are available from the MDRs and PRP reporting systems. Because of the limitations cited above, their value to researchers or others is severely restricted. Therefore, efforts to make the data more widely available are not likely to be useful.

SUMMARY

Based on comprehensive scientific reviews of the risks and benefits of dental amalgam, the RWG has identified an extensive list of research opportunities and needs relative to the safety and utility of dental amalgam and alternative dental restorative materials. Additionally, a smaller list of high priority research areas has been drawn from the comprehensive list, based on the potential to provide a sound basis for public health decision making about the continued use of dental amalgam.

There are enough areas of fundamental research merited, both in terms of low level mercury effects on human health in general and mercury vapor from dental amalgam in particular, that definitive answers will require research efforts over a period of many years. The available research evidence is not specific enough or strong enough to make sound pronouncements about human health risks from dental amalgam. Given the potential that end effects from low levy mercury exposure may well be subtle and non-specific and that the relative importance of various forms and sources of mercury are not clearly established, much work remains.

At the same time, it is encouraging that a wide range of research is already being conducted that should help to answer questions of potential mercury toxicity, as well as the safety and utility of alternative dental restorative materiels. A tracking system has been proposed that will permit the ongoing assessment of research efforts that bear on these questions. Agencies that carry out or sponsor research related to these questions could utilize the tracking system to assess how their resources could best be applied to addressing the most important scientific questions for making sound public policy decisions.

Unlike many areas of potential health risk where extensive research remains to be conducted, a marked decline in exposure to the potential risk agent is already taking place as a result of declining caries rates, improved dental materials and treatment methods, and preference of the public for tooth colored rather than metal colored restorations.

Attachment 1

Dental Amalgam Research Questions/Work Statements
(non-prioritized) Identified from the "Risks" and "Benefits"Reports1

1 Major dental amalgam research gaps were identified in the response to Charge 1 and priority areas and methodological issues were listed in the response to Charge 2.

Attachment 2

Draft Selection of PHS Supported Research Potentially Related
to Dental Amalgam Risks and Benefits

Project ID

Project Title

Award

Fiscal
Year

5 P01 AG05119-07
SUB:0003

Biochemical, morphological, and trace element studies—Alzheimer's disease SUB TITLE Trace elements studies in Alzheimer's disease

$143,855

FY91

1 R01 AG10664-01

Alzheimer's disease, dental amalgams and mercury (human)

$165,615

FY91

1 P60 AR40770-OIA1
SUB:0002

Multipurpose arthritis and musculoskeletal diseases center
SUB Title Evaluation of new animal model of systemic autoimmunity

$100,902

FY91

2 R01 DE02936-23

Relationship of microstructure to behavior of amalgam (human)

$158,172

FY91

2 R55 DE06112-09A1

Filled sealant as a conservative restorative material

$100,000

FY91

5 R37 DE06374-10

Semi-and nonprecious metal-porcelain systems

$226,593

FY91

5 R01 DE0653948

Breakdown of amalgam margins—A microstructural study (human)

$175,486

FY90

5 R01 DE06563-08

Microstructure vs. deterioration of amalgam restorations

$70,179

FY91

5 R01 DE06672-09

Optimization of restoration design

$168,803

FY91

5 R01 DE07644-06

Evaluation of mercury release from dental amalgam

$139,889

FY91

5 R01 DE07754-06

Dissolution of mercury from dental amalgams

$146,685

FY91

5 R01 DE07806-06

Thermally induced changes in dental porcelain expansion

$117,088

FY91

5 R01 DE08222-02

Optimizing corrosion testing of dental alloys (humans)

$152,693

FY91

5 R01 DE08651-03

Evaluation of protection hypothesis for composite wear (humans)

$188,571

FY91

5 R01 DE08587-03

Mercury and leukocyte function (human)

$173,066

FY91

5 R44 DE08905-03

Low-noble metal content duplex dental alloys

$219,945

FY91

1 R15 DE08984-01

Expanding composite matrixes for dental restoration

$51,935

FY89

1 R01 DEO9292-01A1

In vivo/in vitro wear performance of posterior composite (human)

$184,568

FY91

5 P50 DE09307-03
SUB:0001

Specialized materials science research center SUB TITLE

Controlled release of diagnostic and therapeutic agents

$178,913

FY91

1 P01 DE09696-01
SUB:0002

Improved polymeric restorative through molecular design
SUB TITLE Surface characterization of dental restorative resins

$131,650

FY91

3P30ES00159-24S1
SUB:003

Environmental health sciences center
SUB TlTLE Toxic and essential metals (rat, rabbit, human)

$146,942

FY91

5 K04 ES00163-04

Mechanism of mercury toxicity and carcinogenicity cells

$64,730

FY91

5 K04 ES00178-04

Neurotoxic mechanism of methylmercury poisoning

$70,200

FY91

5 P30 ES01247-18
SUB:9005

Environmental Health Sciences Center
SUB TITLE Clinical studies—Neurotoxicology (human)

$206,504

FY91

5 P30 ES01247-17
SUB:0082

Trace contaminants as environmental heath hazards to man
SUB TITLE Neurobehavioral toxicity of metals (mice)

$64,304

FY91

5 R01 ES02453-12

Renal reabsorption of glutamate (rabbits, rats)

$120,188

FY91

5 R01 ES02573-09

Mercury neurotoxicitive role of lipoperoxidation injury

$104,880

FY90

5 R01 ES02654-10

Genetics of thionein and tolerance to metals (Drosophila)

$161,986

FY91

5 R01 ES02928-10

Effects of methylmercury on fetal brain (mice, human)

$246,859

FY90

5 R01 ES03179-09

Immunotoxicology of heavy metals (mice, human)

$187,387

FY91

2 R01 ES03230-04A2

Immune effects of metals—Mercury-induced autoimmune disease (rats)

$139,039

FY91

5 R01 ES03299-08

Neurotoxic mechanism of acute methylmercury poisoning
(rats, mice, guinea pigs)

$116,905

FY9I

5 R01 ES03543-05

Epigenetic mechanisms of toxicity of environmental metals

$126,950

FY91

5 R01 ES03628-06

Trace metal alteration of renal porphyrin metabolism (rats)

$108,883

FY91

5 R01 ES03745-05

Primate developmental effects of methyl mercury (Macaca, rats) (Repro/Devel)

$281,572

FY91

5 R01 ES03928-06

Neurotoxic mechanisms in primary CNS cell cultures (mice)

$121,602

FY91

5 R29 ES04722-04

Methyl mercury & neuronal protein phosphotylation (rats)

$87,815

FY91

5 R01 ES04803-04

Effects of xenobiotics on renal membrane transport (rats)

$116,229

FY91

5 P42 ES04895-03
SUB:0005

Detect and predict human exposure to toxic chemicals
SUB TITLE Development of genotoxic assays in lymphocytes

$201,068

FY91

5 P42 ES04895-03
SUB:0008

Detect and predict human exposure to toxic chemicals SUB TlTLE Hair follicle keratinocytes as indicators of toxic and carcinogenic

$201,068

FY9I

5 P42 ES04895-03
SUB:0009

Detect and predict human exposure to toxic chemicals SUB TITLE Bioconcentration and bioaccumulation of chemicals in striped bass

$201,068

FY91

5 P42 ES04895-03
SUB:9002

Detect and predict human exposure to toxic chemicals SUB TITLE Core—Exposure, analytical chemistry and biostatistics

$201,068

FY91

5 R01 ES04976-03

Mechanisms of MeHg neurotoxicity during development (mice)

$144,609

FY91

5 R01 ES05011-03

Long-term organic/inorganic mercury neurotoxicity (macaque)

$274,488

FY91

5 R29 ES05157-04

Mercury nephrotoxicity after a reduction of renal mass (mass)

$85,656

FY91

1 P01 ES05197-OIA1

Health hazards of methylmerury

$724,603

FY91

1 P01 ES05197-OIA1
SUB:0001

Health hazards of methylmercury SUB TITLE Child development following prenatal methyl mercury exposure via fish diet

$120,767

FY91

1 P01 ES05197-OIA1
SUB:0002

Health hazards of methylmercury
SUB TITLE Dosimetry (human)

$120,767

FY91

1 P01 ES05197-OIA1
SUB:9002

Health hazards of methylmercury SUB TITLE Core—Morphology and histochemistry (human tissue)

$120,767

FY91

1 PO1 ES05197-OLA1 SUB:9003

Health hazard of methylmetcury SUB TITLE Core—Analytical

$120,767

FY91

5 RO1 ES05252-02

Effect of Hg and Cd on B lymphocyte function (mice)

$186,378

FY91

5 RO1 ES05372-02

Mechanisms of neurotoxicity

$147,803

FY91

5 RO1 ES05433-02

Late consequences of prenatal exposure to methyl mercury (mice)

$180,228

FY91

2 S14 GM05231-04 SUB:0002

Kentucky State University Research Support Programs
SUB TITLE Induction of cue changes in mammalian cells

$26,041

FY91

5 S06 GM08025-21 SUB 0015

Minority biomedical research support program at Southern University SUB TITLE Bioaccumulation in selected tissues of

$33,191

FY91

5 S06 GM08169-13
SUB:0002

MBRS Program at Selma University
SUB TITLE Biomechanism of heavy metal toxicity (rats)

$75,272

FY91

2 S06 GM08225-07
SUB 0007

Minority biomedical research support at Lehman College SUB TITLE Target sites and compartmentalization in heavy metal exposed cells

$46,928

FY91

5 RO1 GM28211-12

Regulation and structure of the mercury operon (E coli)

$149,449

FY91

5 R29 GM36722~04

Evolution and regulation of mercuric resistance genes (bacteria)

$111,899

FY91

5 R29 GM38784-05

Mechanistic study of the MeRR metalloregulatory protein

$107,255

FY91

5 S06 GM45199-02
SUB:OOO9

Biomedical sciences research improvement program (BSRIP) SUB TITLE Amalgam, urine mercury levels, and cognitive functioning.

$90,621

FY91

5 RO1 NS25165-03

Laser microprobe analysis of neuronal mercury in ALS (human)

$117,400

FY91

5 MO1 RR00095-31 SUB:0319

General clinical research center
SUB TITLE Mercury vapor poisoning (human)

$33,853

FY91

5 P51 RR00166-30 SUB:0078

Regional primate research center SUB TITLE Selenium effects of methylmercury metabolism

$48,810

FY91

5 P51 RR00166-30
SUB:0079

Regional primate research center
SUB TITLE Primate development effects of methylmercury (cynos)

$48,810

FY91

5 P51 RR0016-30
SUB:0104

Regional primate research center SUB TITLE Brain uptake of inorganic mercury (cynos)

$48,810

FY91

ZO1 ES49003-02

Environmental effects on fertility (Hg Occ expose and repro effects in dental assistants)

$0

FY9l

Z01RR10001-23

Pharmacokinetics (PBPK of Hg)

$0

FY9l

 

Attachment 3

1378 Computer Retrieval of Information on Scientific Projects (CRISP)

U. S. National Institutes of Health
Division of Research Grants
Research Documentation Section
Westwood Building, Room 148
5333 Westbard Avenue
Bethesda, Maryland 20892

Basic Information

Provides descriptions and indexing of biomedical research project supported by U.S. Public Health Service grants, cooperative agreements, and career award and research contracts, as well as intramural projects conducted by the National Institutes of Health; the Alcohol, Drug Abuse, and Mental Health Administration; the Centers for Disease Control and Prevention; the Food and Drug Administration; and others. Types of Database: Bibliographic. Language of Database: English. Time span Covered: 1972 to the present. File Size: 625,000 records.

Subject Coverage

Research in biomedical and allied health fields. Input Sources: Applications, progress reports, research contract documents; annual reports, project narratives, and other government documents.

Data Elements

Typical Records Items: Project identification number, title; investigator, address; institution; sponsoring agency; primary terms; project abstract (if furnished)

User Aids

CRISP Thesaurus (annual) - contains more than 10,000 subject headings; available for purchase from the U.S. National Technical Information Service, 5285 Port Royal Rd., Springfield, VA 22161.

Database Availability

Online: BRS Information Technologics. File Label: CRISP. Covers 1986 to the present. Rates/Conditions:

$40 per connect hour (Open Access Plan); discounts available through the Advance Purchase Plan; 15 cents per full record displayed online; 20 cents per full record printed offline. As part of Federal Research in Progress and TOXLINE: each. database is described In a separate entry. Batch Access: Producer offers search services.

Print/lMicroform Products

Publications: Biomedical Index to PHS Supported Research (annual). Intramural Research Index to NIH, NIMH and NIAA Projects (annual).

Contact

James Cain, Chief, Research Documentation Section. Facsimile (301) 496-9975. Electronic Mail: 14C@NIHCU (BITNET).

Return to Table of Contents

Return to Committee Reports Page